CureZone   Log On   Join
Oleander
 
Google Advertisement
Google Advertisement
Google Advertisement
plzchuckle Views: 8,855
Published: 9 years ago
 
This is a reply to # 2,125,468

Oleander



(NaturalNews) A recently concluded FDA phase 1 human toxicity trial of a concentrated oral Oleander extract has found that it can safely be administered
and that it apparently can be effective against a wide number of cancers. The results of the trial were presented at this year's American Society of
Clinical Oncology (ASCO) which was held June 3-7 at Memphis, Tennessee.







The primary purpose of the trial was to determine maximum safe dosage levels. Even so, 7 of the 46 trial participants had their cancers stabilized for 4 or
more months despite the fact that far less than maximum doses were administered for the majority of the trial. The stabilized cancers included bladder,
colorectal, fallopian tube, breast, appendecal and pancreatic carcinomas.







In the trial, patients were given increasing doses of oral Oleander extract in cycles where the drug was administered for 21 out of 28 days in each cycle.
Dosage began at 0.6 mg per day and was slowly increased until a maximum safe dose level of 10.2 mg per day was determined, as indicated in the conclusion
of the trials abstract:







"Conclusions: PBI-05204 is well tolerated up to 10.2/mg/day with very little AEs (adverse events) or cardiotoxicity."







http://www.asco.org/ASCOv2/Meetings/Abstract...






The Oleander extract tested was developed by Phoenix Biotech and used a liquid carbon dioxide extraction method. A previous phase I trial of an injected
aqueous oleander extract never did reach a maximum safe level. Instead the trial was halted when the amount injected became too large to practically
exceed. It has since been determined that the aqueous


extract


can also be administered safely and effectively orally.







The next step in the FDA trial process would be a larger scale multi-location phase II trial. Such a trial will depend on large amounts of funding, perhaps
hundreds of millions of dollars. Even if funding is found, it could take years before the new drug goes through the entire trial process and is available
for cancer patients.







The good news for cancer patients is that


oleander


extract is already available in supplemental form. In addition, a home version of oleander extract can be safely made at home for only pennies. See:






http://www.naturalnews.com/023552_Oleander_c...




http://www.naturalnews.com/023551_Oleander_h...





Note: The oleander plant is very toxic in raw form. Anyone who decides to make a homemade oleander extract should exercise caution in handling raw plant
material and should not deviate at all from the proven instructions. The instructions are based upon the oleander extract developed by noted Turkish doctor
H. Z. Ozel, who has used oleander extract successfully in thousands of patients for over 40 years. It was Dr. Ozel's extract which was tested in the
previous phase I FDA trial.







Success rates for supplemental oleander over the past five years have been reported to be 85% for stage III and IV cancers and 95% for stage I and II


cancer


patients when combined with healthy changes in diet, nutrition, lifestyle and other healthy cancer fighting and immune boosting supplements. One example of
a highly successful protocol which includes oleander and other


natural


items is:






http://www.naturalnews.com/022808_cancer_hea...





Besides cancer, oleander extracts have been found to be very effective against HIV/AIDS, hepatitis-C and other immune disorders. In one double blind
placebo controlled trial conducted at a South Africa AIDS clinic, one of Dr. Swanepoel's oleander extracts was found to be 100% effective in reversing HIV
symptoms and low white blood cell counts.






http://www.naturalnews.com/023243_Oleander_H...





To find out more about the medicinal history and uses of oleander, see:






http://www.naturalnews.com/022951_Oleander_d...




http://www.naturalnews.com/026790_Oleander_c...




http://www.naturalnews.com/023163_cancer_Ole...




http://www.naturalnews.com/023206_cancer_Ole...




http://www.naturalnews.com/025184_cancer_Ole...





Other sources included:






//www.curezone.org/forums/fm.asp?i=1661043


http://www.freepatentsonline.com/7402325.htm...



http://www.clinicaltrials.gov/ct2/show/study...



//www.curezone.org/forums/fm.asp?i=1795312#...





About the author



Tony Isaacs, is a natural health author, advocate and researcher who hosts


The Best Years in Life


website for those who wish to avoid prescription drugs and mainstream managed illness and live longer, healthier and happier lives naturally. Mr. Isaacs is
the author of books and articles about natural health, longevity and beating cancer including "


Cancer's Natural Enemy


" and is working on a major book project due to be published later this year. He is also a contributing author for the worldwide advocacy group "


S.A N.E.Vax. Inc


" which endeavors to uncover the truth about HPV vaccine dangers.





Mr. Isaacs is currently residing in scenic East Texas and frequently commutes to the even more scenic Texas hill country near Austin and San Antonio to
give lectures and health seminars. He also hosts the CureZone "


Ask Tony Isaacs - featuring Luella May


" forum as well as the Yahoo Health Group "


Oleander Soup


" and he serves as a consultant to the "


Utopia Silver Supplement Company


".







More news on oleander









Oleander extract for cancer successfully completes phase I FDA trial




Subscribe to this FREE email newsletter




 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2024  www.curezone.org

0.539 sec, (5)